Genome-wide analysis of FSHD cell lines using Nanopore sequencing reveals allele-specific differences at DUX4 target genes and complex repeats
Preprint
Abstract
Facioscapulohumeral muscular dystrophy (FSHD) is linked to a monoallelic contraction of primate-specific 3.3kb D4Z4 macrosatellite repeats on the disease-permissive chromosome 4q (4qA haplotype) with additional mutations of a chromatin regulator SMCHD1 acting as a disease modifier. DNA hypomethylation at the D4Z4 repeat and resulting abnormal derepression of the embryonic transcription factor DUX4 encoded in the D4Z4 repeat are the hallmark of FSHD. In order to investigate the impact of FSHD mutations within as well as outside of the disease loci, we performed Nanopore direct-RNA and genomic sequencing to characterize global and D4Z4-specific changes in isoform expression and DNA methylation using CRISPR-engineered human skeletal myoblast lines carrying FSHD mutations (D4Z4 contraction and SMCHD1 mutation) compared to the isogenic parental healthy control line. Nanopore sequencing allowed us to characterize the entire unedited control and contracted D4Z4 arrays as well as distinguish differential methylation patterns at the disease locus on chromosome 4qA from those at a nearly identical nonpathogenic D4Z4 repeat arrays on chromosome 10 and disease non-permissive 4qB allele. We observe hypomethylation both at the DUX4 locus and globally in FSHD mutant cell lines in myoblasts as well as in myotubes. DUX4 target gene expression is correlated with promoter hypomethylation. De novo haplotype phasing of genomic and RNA reads reveals allele- and isoform-specific expression of DUX4 target genes as well as highly expressed DUX4 target pseudogenes that may contribute to disease pathogenesis. Taken together, our results indicate significant impact of FSHD mutations not only on D4Z4 allele, but also DUX4 targets and repeat regions in the genome, which may be collectively contributing to the FSHD pathogenesis.Keywords
This publication has 68 references indexed in Scilit:
- A Unifying Genetic Model for Facioscapulohumeral Muscular DystrophyScience, 2010
- Facioscapulohumeral muscular dystrophy region gene-1 (FRG-1) is an actin-bundling protein associated with muscle-attachment sitesJournal of Cell Science, 2010
- Biphasic Myopathic Phenotype of Mouse DUX, an ORF within Conserved FSHD-Related RepeatsPLOS ONE, 2009
- RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophyHuman Molecular Genetics, 2009
- DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiationExperimental Neurology, 2008
- SmcHD1, containing a structural-maintenance-of-chromosomes hinge domain, has a critical role in X inactivationNature Genetics, 2008
- Specific Sequence Variations within the 4q35 Region Are Associated with Facioscapulohumeral Muscular DystrophyThe American Journal of Human Genetics, 2007
- FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patientsJournal of Medical Genetics, 2004
- Genomic Analysis of Human Chromosome 10q and 4q Telomeres Suggests a Common OriginGenomics, 2002
- The DNA rearrangement associated with facioscapulohumeral muscular dystrophy involves a heterochromatin-associated repetitive element: Implications for a role of chromatin structure in the pathogenesis of the diseaseChromosome Research, 1994